Plastic Surgery Practice
  • Client Objectives
    • Aesthetics
    • Dermatology
    • Rejuvenation
  • Practice Management
    • Marketing
    • Office Management
    • Technology
  • Treatment Solutions
    • Innovations
    • Products
    • Pharmaceuticals
  • Resources
    • Podcasts
    • Videos
    • Webinars
    • White Papers

Select Page

Tag: NYU Langone

All

Popular

US News and World Report Names Best Hospitals for Adult Ear, Nose & Throat

US News and World Report announces its rankings of the best ear, nose & throat hospitals for 2015-2016.

  • Economic Trends May Provide Crystal Ball for Aesthetic Surgeons

  • Research Highlights Importance of Blinking After Face Transplantation

  • VIDEO: New Tat Regret: Skin Irritation Risk

  • Study: Viagra, Other ED Drugs Unlikely to Cause Melanoma

  • Surgeons at NYU Langone Medical Center Perform the Most Extensive Face Transplant to Date

  • AAFPRS Highlights the Year in Facial Plastic Surgery

  • Spotlight: What’s Being Talked About This Month

  • NYU Langone Health Performs Its Second Face Transplant

All

Latest
NYU Langone Health Performs World’s First Successful Face & Double Hand Transplant

NYU Langone Health Performs World’s First Successful Face & Double Hand Transplant

This landmark surgical success occurred despite ominous threats from the COVID-19 pandemic, NYU Langone Health reports.

All

Latest
FDA Clears Suction-Based Device for Removal of Ruptured Breast Implants

FDA Clears Suction-Based Device for Removal of Ruptured Breast Implants

The device connects to standard operating room suction and is designed to support faster, more controlled explantation without requiring additional capital equipment or specialized training.

  • Galderma Launches First OBT Hyaluronic Acid Injectables in Japan

    Galderma Launches First OBT Hyaluronic Acid Injectables in Japan

  • How VYC-12L Performs in Treating Horizontal Neck Lines

    How VYC-12L Performs in Treating Horizontal Neck Lines

  • AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib in Vitiligo

    AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib in Vitiligo

Sorry, No Posts Found

Plastic Surgery Practice

7300 W 110th St – Floor 7
Overland Park, KS 66210
(913) 955-2600

Our Parent Company

MEDQOR LLC

About MEDQOR

MEDQOR Data Platform

Press Releases

Key Resources

Podcasts

Webinars

White Papers

Videos

Helpful Links

Media Solutions Kit

Subscribe Now

Contact Us

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Copyright

Privacy Policy

Terms of Service

© 2024 MEDQOR LLC. All Rights Reserved